Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?

dc.contributor.author	Cernuda Morollón, Eva María
dc.contributor.author	Ramón Carbajo, César
dc.contributor.author	Larrosa Campo, Davinia
dc.contributor.author	Álvarez, Rocío
dc.contributor.author	Riesco, Nuria
dc.contributor.author	Pascual Gómez, Julio
dc.date.accessioned	2015-12-21T10:40:11Z
dc.date.available	2015-12-21T10:40:11Z
dc.date.issued	2015
dc.identifier.citation	Cephalalgia, 35(10), p. 864-868 (2015); doi:10.1177/0333102414561873
dc.identifier.issn	0333-1024
dc.identifier.uri	http://hdl.handle.net/10651/34269
dc.description.sponsorship	This study was supported by the PI11/00889 FISSS grant (Fondos Feder, ISCIII, Ministry of Economy, Spain)
dc.format.extent	p. 864-868
dc.language.iso	eng
dc.relation.ispartof	Cephalalgia
dc.rights	©,
dc.source	Scopus
dc.source.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-84938774792&partnerID=40&md5=1a54857a7cb99807f8e1cae145eb26ce
dc.title	Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
dc.type	journal article
dc.identifier.doi	10.1177/0333102414561873
dc.relation.publisherversion	http://dx.doi.org/10.1177/0333102414561873

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.